COVID-19 cases and figures 12-25 January (Twitter)
KUALA LUMPUR: Malaysia’s Health Ministry plans to complete the COVID-19 vaccination programme in the country by the end of 2021 or early next year.
Health director-general Dr Noor Hisham Abdullah said the vaccination programme would involve three phases with the first phase expected to start in March involving half a million vaccines for frontline workers.
“We hope to receive the first vaccine at the end of next month. We expect the (first phase) of vaccinations to be from March to May with the second dose being administered 21 days after receiving the first dose,” he said.
MOH committed to ensuring safety of registered vaccines 18 Jan 2021 / 22:39 H.
KUALA
LUMPUR: The Ministry of Health (MOH) is always committed to ensuring the quality, safety and effectiveness of vaccines and registered medicines are always guaranteed through the quality product monitoring programme and pharmacovigilance.
Its Minister Datuk Seri Dr Adham Baba (
pix), in a statement today said the ministry would notify the public of the latest developments on the registered vaccines, from time to time.
“Those who experience adverse effects after receiving a vaccine can lodge reports to any healthcare facilities that administer vaccines or submit them to NPRA (the National Pharmaceutical Regulatory Division) through its website at https://npra.gov.my,” he said.
Published on: Friday, December 18, 2020
By: Bernama
Text Size:
Kuala Lumpur: The selection of the Covid-19 vaccine produced by international pharmaceutical company Pfizer is based on an interim report of clinical trials of its effectiveness level, which is 95 percent, the Dewan Rakyat was told Thursday.
Science, Technology and Innovation Minister Khairy Jamaluddin
(pic) said the report was published in The New England Journal of Medicine on Dec 10, and even the government had access to the data to assess the quality, safety and effectiveness of the vaccine.
“The vaccine has also received the Emergency Use Authorisation from seven countries, including the United Kingdom, the United States, Bahrain, Canada, Saudi Arabia, Mexico and Singapore.
17 Dec 2020 / 12:48 H. The government had access to the data to assess the quality, safety and effectiveness of the vaccine.
KUALA LUMPUR: The selection of the Covid-19 vaccine produced by international pharmaceutical company Pfizer is based on an interim report of clinical trials of its effectiveness level, which is 95 percent, the Dewan Rakyat was told today.
Science, Technology and Innovation Minister Khairy Jamaluddin said the report was published in The New England Journal of Medicine on Dec 10, and even the government had access to the data to assess the quality, safety and effectiveness of the vaccine.
“The vaccine has also received the Emergency Use Authorisation from seven countries, including the United Kingdom, the United States, Bahrain, Canada, Saudi Arabia, Mexico and Singapore.
Pfizer s Covid-19 vaccine effectiveness level is 95%, Dewan Rakyat told theedgemarkets.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theedgemarkets.com Daily Mail and Mail on Sunday newspapers.